Utilization and uptake of clinical genetics services in high-income countries: a scoping review

N Dragojlovic, N Kopac, K Borle, R Tandun, S Salmasi… - Health Policy, 2021 - Elsevier
Ongoing rapid growth in the need for genetic services has the potential to severely strain the
capacity of the clinical genetics workforce to deliver this care. Unfortunately, assessments of …

Data resource profile: better outcomes registry & network (BORN) Ontario

MSQ Murphy, DB Fell, AE Sprague… - International Journal …, 2021 - academic.oup.com
Ontario Midwifery Program and the Niday Perinatal Database. These programmes worked
together to normalize their data and build a robust, web-based data-collection and reporting …

[HTML][HTML] Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany

H Borth, A Teubert, R Glaubitz, S Knippenberg… - Archives of gynecology …, 2021 - Springer
Purpose Noninvasive prenatal testing (NIPT) is a highly sensitive and specific method for
detection of fetal chromosomal aneuploidies from maternal plasma. The objective of this …

Non‐invasive prenatal test uptake in socioeconomically disadvantaged neighborhoods

KRM van der Meij, C Kooij, MN Bekker… - Prenatal …, 2021 - Wiley Online Library
Abstract Objective Non‐Invasive Prenatal Testing (NIPT) is increasingly being implemented
worldwide. In public health programs, equitable access to healthcare is a fundamental …

Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers

A Benachi, J Caffrey, P Calda, E Carreras… - European Journal of …, 2020 - Elsevier
Cell-free DNA-based noninvasive prenatal testing (cfDNA) is a relatively new screening tool
that analyzes cfDNA circulating in maternal plasma to screen for aneuploidies. Since its …

[HTML][HTML] Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December …

DB Fell, E Török, AE Sprague, AK Regan, T Dhinsa… - Vaccine, 2023 - Elsevier
Background Population-based COVID-19 vaccine coverage estimates among pregnant
individuals are limited. We assessed temporal patterns in vaccine coverage (≥ 1 dose …

A 2‐year review of publicly funded cell‐free DNA screening in Ontario: utilization and adherence to funding criteria

K Bellai‐Dussault, L Meng, T Huang… - Prenatal …, 2020 - Wiley Online Library
Objective Ontario offers a publicly funded modified contingent model of prenatal screening
for aneuploidy in which cell‐free DNA (cfDNA) screening is covered for pregnancies at …

Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic Outcomes

K Bellai-Dussault, SD Dougan, DB Fell… - JAMA Network …, 2024 - jamanetwork.com
Importance Ultrasonographic measurement of fetal nuchal translucency is used in prenatal
screening for trisomies 21 and 18 and other conditions. A cutoff of 3.5 mm or greater is …

The impact of maternal and geographical factors on the uptake of non‐invasive prenatal testing: A retrospective cohort study

AA Tweneboa Kodua, DB Fell, C Armour… - Prenatal …, 2022 - Wiley Online Library
Objectives The objectives of this study were to investigate recent trends in non‐invasive
prenatal testing (NIPT) utilisation, including factors associated with geographical variation …

Supporting patient autonomy and informed decision-making in prenatal genetic testing

K Stoll, J Jackson - Cold Spring Harbor …, 2020 - perspectivesinmedicine.cshlp.org
Genetic counselors have both the burden and the privilege of supporting patients who are
faced with making difficult decisions. In the prenatal setting, genetic counselors are …